Journal
KIDNEY INTERNATIONAL
Volume 75, Issue 6, Pages 580-582Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2008.663
Keywords
-
Categories
Ask authors/readers for more resources
Arterial calcification has been found to coexist with bone loss. Bisphosphonates, used as standard therapy for osteoporosis, inhibit experimentally induced vascular calcification, offering perspectives for the treatment of vascular calcification in renal failure patients. However, Lomashvili et al. report that the doses of etidronate and pamidronate that are effective in attenuating aortic calcification also decrease bone formation and mineralization in uremic rats, limiting their therapeutic use as anticalcifying agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available